- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02723565
Ultrasound to Evaluate Failure of Liberation From Mechanical Ventilation (USEFUL)
March 26, 2019 updated by: Ewan Goligher, University Health Network, Toronto
This study will evaluate the heart, lungs and diaphragm of patients who fail a trial of spontaneous breathing to determine the physiological mechanism of weaning failure.
Study Overview
Status
Completed
Detailed Description
The transition to unassisted breathing after invasive ventilation often proves challenging, with over 40% of patients failing their first attempt of unassisted breathing.
Persistent ventilator dependence predisposes patients to nosocomial complications and increases the economic burden of critical illness.
Ventilator-dependence results from an imbalance between the load and capacity of the respiratory muscle pump.
Patients who fail a trial of spontaneous breathing commonly exhibit excess respiratory loads secondary to weaning-induced pulmonary edema, atelectasis or dynamic hyperinflation.
Many patients who are dependent on the ventilator also show a striking loss of pump capacity due to diaphragm dysfunction.
Though each of these mechanisms respond to specific interventions, it is often difficult for physicians to discern which mechanisms are at play at the bedside.
Bedside ultrasound is a potentially useful means of evaluating cardiac, pulmonary and diaphragm function during weaning failure.
It is readily available, highly feasible and already widely employed in clinical practice.
As yet, no study has evaluated the accuracy and feasibility of combining echocardiography with lung and diaphragm ultrasound to comprehensively evaluate the physiological mechanisms of weaning failure.
The objectives of this study are to establish the utility of a rapid thoracic ultrasound exam to diagnose mechanisms of ventilation liberation failure and to assess the relationship between cardiothoracic variability during spontaneous breathing and different physiological mechanism of weaning failure.
Study Type
Observational
Enrollment (Actual)
7
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 1W8
- St. Michael's Hospital
-
Toronto, Ontario, Canada, M5G 1X5
- Mount Sinai Hospital
-
Toronto, Ontario, Canada, M5G 2N2
- University Health Network
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients in the intensive care unit.
Description
Inclusion Criteria:
- patients over 18 years of age receiving invasive mechanical ventilation for at least 24 hours
- patients who fulfill standard criteria for readiness for a trial of spontaneous breathing (no or minimal sedation, patient awake and interactive; minimal vasopressor/inotrope requirements (Norepinephrine < or = 0.1, Dopamine < 10, Vasopressin/Epinephrine off); fraction of inspired oxygen < or = 50%; spontaneous inspiratory efforts as indicated by patient-triggered breaths; positive end-expiratory pressure < or = 10 cm H20)
- patients who fail a trial of spontaneous breathing (transient reduction of ventilator support for any duration up to 2 hours as per local ICU practice - typically PS 5 with PEEP 5 OR CPAP 5 OR T-piece)
Exclusion Criteria:
- patients with a coagulopathy (INR > 2.5, platelet count < 30x10^6/L) or previously diagnosed bleeding diathesis or are receiving anticoagulant drugs at therapeutic doses (ie. excluding venous thromboembolic prophylaxis)
- patients with a contraindication to nasogastric tube insertion (esophageal varices, upper GI tract surgery, facial trauma, etc.)
- patients receiving extra-corporeal life support
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity and specificity for diagnosis of physiological mechanisms causing weaning failure
Time Frame: Physiological measurements for diagnostic classification measured simultaneously with ultrasound measurements
|
Mechanisms responsible for weaning failure will be diagnosed by field experts using clinical data collected from the chart along with physiological measurements (respiratory mechanics, maximal inspiratory pressure, markers of pulmonary edema including changes in serum total protein and BNP and central venous pressure).
The diagnosis derived from a pre-specified ultrasound-based classification system will be compared to the gold standard expert-derived diagnosis.
|
Physiological measurements for diagnostic classification measured simultaneously with ultrasound measurements
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
March 24, 2016
First Submitted That Met QC Criteria
March 24, 2016
First Posted (Estimate)
March 30, 2016
Study Record Updates
Last Update Posted (Actual)
March 28, 2019
Last Update Submitted That Met QC Criteria
March 26, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-7400-B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Failure
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
Hospices Civils de LyonRecruitingAcute Respiratory FailureFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Respiratory FailureFrance
-
Laval UniversityRecruitingAcute Respiratory Failure | Hypoxemic Acute Respiratory Failure | High Flow Oxygen Therapy | Oxygen DeliveryCanada
-
Peking Union Medical College HospitalRecruitingAcute Respiratory Failure (ARF)China
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingAcute Respiratory Failure (ARF)Italy
-
Southeast University, ChinaNot yet recruitingAcute Respiratory Failure (ARF)
-
Dr. Behcet Uz Children's HospitalCompletedAcute Respiratory Failure | Acute Hypoxemic Respiratory Failure | Acute Hypoxemic and Hypercapnic Respiratory FailureTurkey
-
Muhammed Ata Nur GEÇERBakirkoy Dr. Sadi Konuk Research and Training HospitalNot yet recruitingPediatric | Pediatric Acute Upper Respiratory Tract Infection | Pediatric Acute Respiratory Failure
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...RecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureCanada